Diabetic kidney disease in Australia: Current burden and future projections

Nephrology

Volumn 19, Issue 8, 2014, Pages 450-458

  White, Sarah ^a   Chadban, Steve ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

chronic kidney disease; diabetic nephropathy; end stage kidney disease; epidemiology

Indexed keywords

AUSTRALIA; DIABETES MELLITUS; END STAGE RENAL DISEASE; EPIDEMIOLOGY; HEALTH CARE COST; HUMAN; KIDNEY DISEASE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; COST OF ILLNESS; DIABETIC NEPHROPATHIES; ECONOMICS; FORECASTING; KIDNEY FAILURE, CHRONIC;

AUSTRALIA; COST OF ILLNESS; DIABETIC NEPHROPATHIES; FORECASTING; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 84904887710     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12281     Document Type: Review

References (39)

1. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. Lancet 2012; 380: 1662-1673.
2. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003; 63: 225-232.
3. Finne P, Reunanen A, Stenman S, Groop P-H, Grönhagen-Riska C,. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005; 294: 1782-1787.
4. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J, Linköping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study. Diabetologia 2004; 47: 1266-1272.
5. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2012 Annual Data Report. Am. J. Kidney Dis. 2013; 61 (1 Suppl 1): A7, e1-476.
6. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J,. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011; 305: 2532-2539.
7. MacIsaac RJ, Jerums G,. Diabetic kidney disease with and without albuminuria. Curr. Opin. Nephrol. Hypertens. 2011; 20: 246-257.
8. Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J. Am. Soc. Nephrol. 2013; 24: 302-308.
9. Clayton P,. 36th Annual ANZDATA Report: Appendix A: Incidence data 2012. Adelaide: Australia and New Zealand Society of Nephrology; 2013. [Cited 19 May 2014.] Available from URL: http://www.anzdata.org.au/v1/report-2013.html
10. Grace BS, Clayton P, McDonald SP,. Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy. Nephrology 2012; 17: 76-84.
11. Muntner P, Coresh J, Powe NR, Klag MJ,. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J. Am. Soc. Nephrol. 2003; 14: 1568-1577.
12. Clayton P,. 36th Annual ANZDATA Report: Appendix B: Prevalence data. 2012. Adelaide: Australia and New Zealand Dialysis and Transplant Registry. [Cited 19 May 2014.] Available from URL: http://anzdata.org.au/v1/report-2013. html
13. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH,. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303-1309.
14. Fuller JH, Stevens LK, Wang SL,. Risk factors for cardiovascular mortality and morbidity: The WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl 2): S54-64.
15. Go A, Chertown GM, Fan D, McCulloch C, Hsu C,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296-1305.
16. Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study. Lancet 2012; 380: 807-814.
17. Debella YT, Giduma HD, Light RP, Agarwal R,. Chronic kidney disease as a coronary disease equivalent-a comparison with diabetes over a decade. Clin. J. Am. Soc. Nephrol. 2011; 6: 1385-1392.
18. Multiple causes of death in Australia: An analysis of all natural and selected chronic disease causes of death 1997-2007 [Internet], 105 edn. AIHW Bulletin, Canberra; 2012. [Cited 19 May 2014.] Available from URL: http://www.aihw.gov.au/publication-detail/?id=10737422603
19. McBrien KA, Manns BJ, Chui B, et al. Health care costs in people with diabetes and their association with glycemic control and kidney function. Diabetes Care 2013; 36: 1172-1180.
20. Lee CMY, Colagiuri R, Magliano DJ, et al. The cost of diabetes in adults in Australia. Diabetes Res. Clin. Pract. 2013; 99: 385-390.
21. US Renal Data System. USRDS 2013 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethseda, MD; 2013. [Cited 19 May 2014.] Available from URL: http://www.usrds.org/atlas.aspx
22. Magliano DJ, Shaw JE, Shortreed SM, et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008; 51: 2179-2186.
23. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
24. Australian Institute of Health and Welfare. Diabetes Deaths, 2013. [Cited 19 May 2014.] Available from URL: http://www.aihw.gov.au/diabetes-indicators/ deaths
25. Magliano DJ, Peeters A, Vos T, et al. Projecting the burden of diabetes in Australia-what is the size of the matter? Aust. N. Z. J. Public Health 2009; 33: 540-543.
26. Bennett PH, Lee ET, Lu M, Keen H, Fuller JH,. Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl 2): S37-45.
27. Lee ET, Keen H, Bennett PH, Fuller JH, Lu M,. Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: General description and morbidity. Diabetologia 2001; 44 (Suppl 2): S3-13.
28. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H,. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 2001; 44: S14-21.
29. ESRD Incidence Study Group, Stewart JH, McCredie MRE, Williams SM,. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002. Diabet. Med. 2006; 23: 1364-1369.
30. Keen H,. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl 2): S1-2.
31. Burrows NR, Li Y, Geiss LS,. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010; 33: 73-77.
32. Walls HL, Magliano DJ, Stevenson CE, et al. Projected progression of the prevalence of obesity in Australia. Obesity 2012; 20: 872-878.
33. Palmer AJ, Valentine WJ, Chen R, et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol. Dial. Transplant. 2008; 23: 1216-1223.
34. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR,. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 2003; 290: 3101-3114.
35. Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am. J. Kidney Dis. 2010; 55: 463-473.
36. Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: Cost effectiveness study. BMJ 2010; 341: c5869.
37. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: Follow-up of cross sectional health survey. BMJ 2006; 333: 1047.
38. James MT, Hemmelgarn BR, Tonelli M,. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375: 1296-1309.
39. Mozaffarian D, Afshin A, Benowitz NL, et al. Population approaches to improve diet, physical activity, and smoking habits: A scientific statement from the American Heart Association. Circulation 2012; 126: 1514-1563.